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Background: An estimated 366 million people are living with diabetes worldwide and it is predicted that its
prevalence will increase to 552 million by 2030. Management of this disease and its complications is a challenge for
many countries. Optimal glycaemic control is necessary to minimize complications, but less than 70% of diabetic
patients achieve target levels of blood glucose, partly due to poor access to qualified health care providers.
Telemedicine has the potential to improve access to health care, especially for rural and remote residents. Video
teleconsultation, a real-time (or synchronous) mode of telemedicine, is gaining more popularity around the world
through recent improvements in digital telecommunications. If video consultation is to be offered as an alternative
to face-to-face consultation in diabetes assessment and management, then it is important to demonstrate that this
can be achieved without loss of clinical fidelity. This paper describes the protocol of a randomised controlled trail
for assessing the reliability of remote video consultation for people with diabetes.
Methods/Design: A total of 160 people with diabetes will be randomised into either a Telemedicine or a
Reference group. Participants in the Reference group will receive two sequential face-to-face consultations whereas
in the Telemedicine group one consultation will be conducted face-to-face and the other via videoconference. The
primary outcome measure will be a change in the patient’s medication. Secondary outcome measures will be
findings in physical examination, detecting complications, and patient satisfaction. A difference of less than 20% in
the aggregated level of agreement between the two study groups will be used to identify if videoconference is
non-inferior to traditional mode of clinical care (face-to-face).
Discussion: Despite rapid growth in application of telemedicine in a variety of medical specialities, little is known
about the reliability of videoconferencing for remote consultation of people with diabetes. Results of this proposed
study will provide evidence of the reliability of specialist consultation offered by videoconference for people with
diabetes.
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Keywords: Diabetes, Telemedicine, Remote consultation, Videoconferencing, Video teleconsultation, Video
consultation, Video visit* Correspondence: ffatehi@gmail.com
1Centre for Online Health, The University of Queensland, Brisbane, Australia
2School of Advanced Technologies in Medicine, Tehran University of Medical
Sciences, Tehran, Iran
Full list of author information is available at the end of the article
© 2014 Fatehi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
Fatehi et al. BMC Medical Informatics and Decision Making 2014, 14:11 Page 2 of 7
http://www.biomedcentral.com/1472-6947/14/11Background
Diabetes Mellitus (DM) is a common disease with in-
creasing prevalence in many countries. More than 366
million people are estimated to have diabetes worldwide
and it is projected to increase to 552 million by 2030, af-
fecting 9.9% of the global adult population [1]. Managing
diabetes and its complications is very costly, and creates
a substantial burden on the health care economy. There
is no cure; instead optimal glycaemic control is required
to minimize complications [2]. However, less than 70%
of people with diabetes are achieving target glycaemic
control, demonstrating that effective disease manage-
ment for people with diabetes remains a challenge [3,4].
For some patients, particularly in rural areas, not achiev-
ing target glycaemic controls is at least in part due to
poor access to qualified health care providers [5,6]. In
response to the growing demand for health care and a
decreasing availability of health care providers, informa-
tion and communications technology (ICT) has shown
potential to improve the accessibility of health care ser-
vices and to reduce costs of health care delivery [7].
Telemedicine is the provision of medical and health ser-
vices remotely using information and communication
technology [8]. The telemedicine interactions are generally
divided into two categories: synchronous (occurring in real
time such as videoconferencing) and asynchronous (store-
and-forward solutions such as transmission of a blood glu-
cose level from a glucometer to a health centre).
Asynchronous (store-and-forward) telemedicine has
been successfully implemented in the medical specialities
such as pathology [9], radiology [10] and dermatology [11]
where real time exchange of information between health
care providers and consumers is not essential. In contrast,
synchronous telemedicine requires both parties to interact
with each other in real time using communication technol-
ogy. Among the synchronous telemedicine solutions,
videoconferencing – real time exchange of voice and
image - is becoming popular through rapid achievements
in digital communication technology. Video teleconsulta-
tion has been used in a wide range of disciplines from
emergency medicine [12] to mental health [13], but it has
been emphasized that most existing disciple-specific studies
cannot be generalized to other tele-medical contexts [14].
In a systematic review on synchronous and asynchronous
teleconsultation for diabetes care, Verhoeven et al. sug-
gested that both teleconsultation solutions are feasible,
cost-effective and reliable for delivering diabetes care. How-
ever they identified a lack of high quality studies and diver-
sity in the included studies [15]. Several studies have
reported results of using videoconferencing for diabetes
care. However, almost all used videoconferencing for be-
havioural therapy including diabetes education, self-
management training, nutrition counselling, and collabora-
tive goal setting [16]. The accuracy of videoconferencingfor specialist telediagnosis and assessment of selected dis-
eases has been studied (e.g., Alzheimer’s disease) [17], but
there is no published study on the reliability and accuracy
of videoconferencing for clinical consultation with regard
to medical specialist evaluation and management of dia-
betic patients.
If a doctor is able to assess and manage a diabetic patient
via videoconference with a similar level of reliability as a
face-to-face consultation, the medical profession could have
confidence in including video consultation as a regular as-
pect of their clinical care. A clinician who regularly sees pa-
tients for evaluation of their diabetic management may
choose to substitute some of the regular face-to-face con-
sultations with a video consultation. This has important
implications for patients isolated by either their physical lo-
cation (e.g., rural communities) or their function (e.g., dis-
abled older people in aged care facilities) and paves the way
for at least some specialist consultation for people living in
rural or remote areas to avoid the expense and inconveni-
ence of long distance travel. It may also increase the oppor-
tunities for some people to receive advice in situations
where they previously may have not, due to an inability to
travel. This protocol describes a research project that will
evaluate the reliability of clinical decisions made during a
diabetic patient consultation via videoconference.
Typically the aim of a Randomized Controlled Trial
(RCT) is to identify if superiority exists between two or
more parallel groups to guide decision making, for example
whether to replace a current medication or procedure with
a new one. However, an alternative analytical approach is
required when the aim is to identify if an innovation is suit-
able to replace an existing process at the same level of
efficacy [18]. Such methodology is referred to as a non-
inferiority trial. A priori defined level of clinically acceptable
variation between the two modes of delivery is used to de-
termine the outcome. This study is a non-inferiority trial
comparing the clinical outcomes of video consultations
against those of conventional face-to-face consultations.
Aims and objectives
In this study we are seeking to identify if telemedicine is
a reliable vehicle for providing specialty consultation for
people with diabetes using videoconferencing, with the
implication that it would be useful to utilise when usual
care is either not available or difficult to deliver. The
aim of the study is to test the level of clinical agreement
achieved using specialist to patient videoconferencing
(VC) compared with face-to-face (FTF) consultation. To
place this level of agreement in context, it will also es-
tablish the level of agreement among specialists using
face-to-face consultation. This approach enables the
variation in clinical decision making among clinicians to
be identified, and thus to be differentiated from the ef-
fect of the VC mode of service delivery.
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ment and recommendations as determined by an alteration
in medication type or dose made by endocrinologists for
people with diabetes via videoconference are significantly
different from those made through face-to-face consult-
ation (null hypothesis). Secondary hypotheses will apply the
same analytic techniques to the other aspects of diabetes
consultation: (i) ordering lab tests or other diagnostic inter-
vention; (ii) initiation of new medication(s) or dose adjust-
ment of the previously prescribed drugs for dyslipidaemia
and/or hypertension; (iii) detection or management of dia-
betes related complications; and (iv) referring to other spe-
cialists or arranging hospital admission.
Methods/design
This study is a repeated-measure non-inferiority random-
ized controlled trial. All patients participating in the study
will receive two consultations (one original consultation
and one additional consultation; called paired-consultation
in this paper) by two different endocrinologists. Level of
agreement between the recommendations made viaVC ver-
sus FTF for the same patient by two endocrinologists will be
calculated. This constitutes VC-FTF paired-consultations.
Since there is likely to be a certain level of clinical variability
between clinicians, the level of agreement in VC-FTF
paired-consultations will then be compared against the level
of agreement between two endocrinologists when they con-
sult a patient in standard clinical practice (FTF-FTF). This
arrangement will determine whether any lack of agreement
is likely to be a result of the videoconference modality, or
just normal variation between doctors.
Study setting and participants
This study will be conducted in the outpatient diabetes
clinic of the Princess Alexandra Hospital (PAH) which is a
tertiary teaching hospital in Brisbane, Australia. People
with diabetes who have an appointment with an endocrin-
ologist as a new or review case for the purpose of improv-
ing management of their diabetic condition will be
approached and invited for participation. Six endocrinolo-
gists who attend the clinic routinely will visit the patients
as scheduled (these are referred to as ‘routine endocrinolo-
gists’ in this paper). Another endocrinologist (referred to
as the ‘research endocrinologist’ in this paper) will be
employed for the purpose of this research to undertake
the additional consultation for each patient who consents
to participate in the trial. The additional consultation will
be conducted by the research endocrinologist prior to the
original consultation for each patient. However, the par-
ticipant patients will receive both their consultations on
the same day in the same clinic session. The routine and
research endocrinologists are all specialist doctors with
the same qualifications and credentials (i.e. accredited by
the Royal Australian College of Physicians).Inclusion and exclusion criteria
Eligible participants include patients (i) with a confirmed
diagnosis of diabetes, (ii) who are 18 years of age or
older. Patients will be excluded if (i) they are severely ill,
(ii) unable to communicate effectively (blind, deaf, mute,
etc.), or (iii) speak in a language other than English if an
interpreter is not available.
Randomisation
Participants will be randomly allocated in a 1:1 ratio into
one of two study groups (Telemedicine or Reference
group). In the Telemedicine group the participants will
receive a paired-consultation in which one of the consul-
tations is via video (FTF-VC or VC-FTF), but in the Ref-
erence group both consultations will be face-to-face
(FTF-FTF). Figure 1 outlines the randomisation and
allocation process. The first consultation in each paired-
consultation will be provided by the research endocrin-
ologist, whereas the second consultation will be provided
by one of the routine endocrinologists of the clinic.
Since the order of VC vs. FTF consultations are also ran-
domised, there will be three potential configurations for
the paired consultations of each participant (Table 1).
With such design, half of the video consultations will be
conducted by the research endocrinologist, and the
other half by the routine endocrinologists of the clinic.
A block randomisation with the block size of eight
will be used to ensure balanced representation of the
participants in each group. The randomised configur-
ation will be provided by an independent biostatistician
using SAS software. Opaque sealed envelopes with se-
quential numbers will be used for allocating the partici-
pants into the groups.
Informed consent and recruitment
Eligible patients will be contacted by phone prior to
their appointment to explain the project and seek verbal
consent. Once checked-in to the clinic for their appoint-
ment, patients who have verbally consented will be given
the participant information sheet, and written consent
will be obtained. Each participant will be offered two
movie vouchers (valued roughly US$ 30.00) as a com-
pensation and appreciation for participating in this
study. Non-consenting or excluded patients will receive
their routine service at the clinic.
Usual care
Princess Alexandra Hospital operates three diabetes clinics
a week in the outpatient clinic building. New patients are
allocated a 45-minute, and review patients usually a 30-
minute time slot for consultation. Wherever possible,
review patients are scheduled to see the same endocrin-
ologist they saw for their previous appointment to ensure
continuity of care.
Figure 1 Flow diagram of randomisation and allocation to paired consultations method.
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by a diabetes nurse practitioner and initial assessments
such as measuring weight and blood pressure are per-
formed. The nurse also downloads the blood glucose
readings from the patient’s glucometer and updates the
patient charts with the latest lab results. The patient
then visits the endocrinologist. At the conclusion of the
consultation, the doctor writes the progress notes and
any pharmacy scripts that are required, requests path-
ology test(s), refers the patient to another specialist or
other health professional where indicated, or arranges
for hospital admission if needed. The patient is then
scheduled for another follow up outpatient appointment,
or care is transferred back to the referring GP with a
management plan.Table 1 Potential configurations of paired consultations
for randomisation














FTF: Face-to-Face, VC: Videoconference.Intervention
All participants, both in the Telemedicine and Refer-
ence groups, will receive an additional consultation
(consultation 1) by the research endocrinologist who is
employed for this study. This endocrinologist is offi-
cially qualified and credentialled to visit and manage
patients at the clinic. The additional consultation will
always occur prior to the original consultation (consult-
ation 2). For the participants in the Reference group,
both consultations will be face-to-face: consultation 1
by the research endocrinologist and consultation 2 by
one of the routine endocrinologists of the clinic. For
the participants in Telemedicine group, one consult-
ation will be face-to-face and the other one via video-
conferencing. The format of the first and second
consultations (FTF-VC, or VC-FTF) for the partici-
pants in this group will be determined in the random-
isation process. The final recommendation for patient
management will be provided by the routine endocri-
nologists at the end of second consultation.
To ensure that the integrity of usual patient care is
maintained for the participants in the Telemedicine
group who will have their second consultation via vid-
eoconferencing (Table 1: configuration 2.2), they will
be able to meet the endocrinologist face-to-face imme-
diately after video-consultation, if required by either
the endocrinologist or the patient.
Table 2 The categories of the impact of medication
change
Medication Change Category
Insulin Initiation of insulin Major





No change No change
Other hypoglycaemic agents Initiation of new drugs Major
Cessation of drugs Major
Dose adjustment Minor
No change No change
Other medications
(hypertension, lipids, etc.)
Initiation of new drugs Major
Cessation of drugs Major
Dose adjustment Minor
No change No change
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To be able to isolate the effect of videoconferencing
from other factors on the outcome of each consultation,
we assume that doctors would have access to the same
patient information as in a face-to-face consultation.
Since the endocrinologist and the patients will be in the
same building for both face-to-face and video consulta-
tions, it will be possible to provide the endocrinologists
with the full records of the patients in hard copy during
the videoconferencing as well as access to the electronic
patient record via the Queensland Health network. Simi-
lar to original consultations, the latest blood glucose
readings will be downloaded from each patient’s gluc-
ometer and entered in the patient record by a practice
nurse upon check-in of each patient to the clinic. That
will ensure that the endocrinologists will have equivalent
access to the latest blood glucose measures, in each of
the paired consultations.
Equipment and connectivity
Remote video consultation will be simulated using one
video-enabled laptop dialling into the diabetes clinic tele-
health studio. The telehealth studio is currently function-
ing and located in the same building of the clinic. For
video consultations, the patient will be accompanied by a
diabetes nurse educator, who will “host” the consultation
and assist with aspects of clinical examination, if needed,
under the direction of the endocrinologist. This arrange-
ment closely emulates the typical situation for diabetes re-
mote consultation by videoconference, where patients are
accompanied either by a nurse or their GP.
The telehealth studio in the diabetes clinic, where the pa-
tient will sit, is equipped with a Tandberg codec 990MXP +
camera unit, Sony Bravia 32” television, and an Audio-
Technica microphone. This codec provides pan, tilt, zoom
functions for the camera by both the local and remote par-
ties. The endocrinologists will use a laptop with 13” screen
and Cisco Telepresence Movi software ver. 4.2 (Cisco sys-
tems, San Jose, California, USA) to connect to the tele-
health studio for conducting the video consultations. Both
Tandberg codec and Cisco Movi are H.264 compliant and
capable of high definition video (up to 1080p 30 fps) encod-
ing and decoding. The laptop has been tested to be com-
patible with the Tandberg codec. This is the configuration
that clinicians use when they provide remote consultations
on a trip or in the facilities that dedicated VC equipment is
not available. The connection will be through the existing
Local Area Network (LAN) and Wireless LAN (WLAN)
within the clinic building. Although the LAN bandwidth is
100 Mbps, the codec and software will be set on 384 Kbps.
This bandwidth is generally regarded as the minimum con-
nection speed for producing acceptable full screen, full mo-
tion video. Although the general connection speeds
between the Queensland Health telehealth centres rangefrom 512 kbit/s to 2.3 Mbit/s depending on site specific
connections, selection of minimum required bandwidth will
ensure the results of this research to be more generalizable
to the countries that high speed networks are not readily
available.
Outcome measures
The outcome measure of this study is the difference in
level of agreement between the two groups. Agreement will
be calculated for each group (Reference group: FTF-FTF;
Telemedicine group: FTF-VC or VC-FTF) and compared.
For the comparison between two consultations to be ac-
curate, it is necessary that the endocrinologists be blinded
to each other’s assessment and recommendations. Part of
this information can be communicated by the patient,
which is inevitable, however the research endocrinologist
has been requested to refrain from giving information
about the assessment and treatment plan to the patient
during the first consultation. Since the research endocrin-
ologist adds nothing to the patient chart (either in hard
copy or electronic records), it will ensure that the endocri-
nologists will be blinded to each other’s opinion on each
patient.
The primary outcome measure is the level of change in
patient’s medications during the consultation. Based on its
impact, medication change is divided into three categories:
Major, Minor, and No change (Table 2). When more than
one category is applicable to a participant, the highest im-
pact will be regarded as the overall impact of the medica-
tion change.
Secondary outcomes focus on performing the physical
examination, detection of diabetes complications and pa-
tient satisfaction. For each video consultation, the endo-
crinologist will be asked about any technical problem or
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standing the barriers of videoconferencing for consulting
people with diabetes.
Data collection
The endocrinologists will complete a questionnaire for
each patient they consult [see Additional file 1]. The
questionnaire will capture various elements of each con-
sultation and comprises 16 questions in three sections:
(1) Patient characteristics, (2) Procedures and findings,
and (3) Recommendations. The questions have been de-
veloped based on the results of two previous studies: ob-
serving conventional face-to-face diabetes consultations,
[19] and process analysis of video teleconsultation for dia-
betes [20]. The questionnaire has been pilot tested in four
consultations and modifications are made to the questions
as suggested by the endocrinologists and the researchers.
The participants in the telemedicine group will also be
asked to complete a patient questionnaire after their video
consultation. This satisfaction questionnaire comprised 17
questions in five-point Likert-type scale asking for various
aspects of videoconference session.
Statistical methods
Demographic and baseline data will be reported as abso-
lute numbers, percentage, and/or mean +/− SD. Percent-
age agreement and the weighted kappa statistic (Kw) will
be used to assess inter-rater reliability between the two
groups on the agreement on assessments and recom-
mendations made by the endocrinologists [21].
Sample size
This study will evaluate if agreement on the recommen-
dations for the Telemedicine group is not inferior to
agreement in the Reference group by more than an ac-
ceptable amount. This clinically acceptable amount of
variation for diabetes consultation was set as 20% by a
group of expert specialist consultants who had more
than five years of telemedicine experience. The sample
size is calculated based on the incidence rates of 25, 50,
25% for major change, minor change, and no change re-
spectively in the patient medication made by the endo-
crinologists (significance level 5%, power 80%). It will be
possible with a total of 160 participants (80 per each
group) to detect any statistically significant difference for
the true kappa of 0.7 and the null kappa of 0.5.
Ethics and trial registration
Ethics approval for this study has been obtained from
the Human Research Ethics Committee of Queensland
Health (HREC/11/QPAH/645 – 12/03/2012) as well
as The University of Queensland School of Medicine
(2011-SOMILRE-0022 – 4/05/2012). This study is also
registered by Australian New Zealand Clinical TrialsRegistry (ANZCTR) as a randomized controlled trial
(ACTRN12612000315819, 20/03/2012).
Discussion
Results of the proposed study will provide an important
and novel insight into provision of clinical consultation
remotely to patients with diabetes by endocrinologists. It
will investigate whether videoconferencing is as reliable
and safe as face-to-face encounter for management of
diabetes. To our best knowledge, this is the first RCT
looking at safety of videoconferencing for specialty con-
sultation of diabetes.
Global prevalence of diabetes has been estimated to in-
crease from 8.3% in 2011 to 9.9% in 2030 among the adult
population [1]. During this period, developing countries will
have a 69% increase in prevalence of diabetes whereas this
increase will be 20% for developed countries [22]. Although
this study has been designed and will be conducted in
Australia which is categorized as a high-income country,
the proposed intervention has potential to be adopted in all
countries that meet the minimum technical requirements
for a videoconferencing with quality accepted for clinical
purposes. The World Health Organization (WHO) has
recommended the incorporation of newer technologies,
such as telecommunications, into the health care system to
improve access to health services in resource limited
countries [23]. Many health centres in low-middle income
countries already have Internet connection that is a pre-
requisite in most of telemedicine interventions including
video teleconsultation, which has been proposed here.
Consultants’ style of clinical practice might be different
from their regular practice while they know they are in-
volved in a research study (Hawthorne effect). However,
this potential effect will equally affect both Reference
and Telemedicine groups. Consultants are also required
to fill in a questionnaire for each consultation in this
study. Items included in the questionnaire that are
derived from observing routine consultations in the
outpatient clinic of a teaching hospital, can act as a
checklist and serve as a decision support system that
possibly improve the process of the consultation, but
again this effect will be equally distributed among the
two groups.
Many hospitals and clinics are currently utilizing elec-
tronic patient records, either as a substitution to the trad-
itional paper-based patient’s records or as a complement
to them. In this study the endocrinologists will have access
to the patient’s complete medical records equally in both
face-to-face and video consultations. This is not the case
in the real world, except for the settings in which the pa-
tient records are fully electronic and accessible via net-
work, and if there is some additional information on hard
copy, that information would be sent to the tele-
consultant before or during the consultation.
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the order of the endocrinologists that the patient will see
and which endocrinologist would provide the final treat-
ment recommendation. This is not able to be performed
due to practical issues involved around ensuring the
smooth running of a busy outpatient clinic as there is not
time for both endocrinologists to discuss each patient and
provide a collaborative management plan.
Despite the rapid growth in telemedicine services in
Australia and official adoptation of videoconferencing as a
mode of delivery for clinical consultations in Australian
health system and worldwide, little has been published on
safety and reliability of videoconferencing for remote con-
sultation of people with diabetes. This study will fill in the
gap of research in the field of telemedicine for diabetes,
and may serve to guide the application of telemedicine to
the management of other chronic diseases.
Additional file
Additional file 1: Analysis of endocrinology consultation.
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